多韦替尼二乳酸
| CAS号 | 852433-84-2 | 货号 | BCP11139 |
| 中文名 | 多韦替尼二乳酸 | ||
| 英文名 | Dovitinib Dilactic acid | ||
| 中文别名 | |||
| 英文别名 | TKI258 Dilactic acid;TKI258; TKI-258; TKI 258; CHIR258; CHIR-258; CHIR 258; | ||
| 分子式 | C27H33FN6O7 | 分子量 | 572.59 |
| 生物活性 | Dovitinib, also known as TKI-258 or CHIR-258, is an orally bioavailable FGFR3 inhibitor, which strongly binds to fibroblast growth factor receptor 3 (FGFR3) and inhibits its phosphorylation, which may result in the inhibition of tumor cell proliferation and the induction of tumor cell death. In addition, this agent may inhibit other members of the RTK superfamily, including the vascular endothelial growth factor receptor; fibroblast growth factor receptor 1; platelet-derived growth factor receptor type 3; FMS-like tyrosine kinase 3; stem cell factor receptor (c-KIT); and colony-stimulating factor receptor 1; this may result in an additional reduction in cellular proliferation and angiogenesis, and the induction of tumor cell apoptosis. | ||
| 信号通路 | Angiogenesis/Protein Tyrosine Kinase | ||
| 靶 点 | PDGFR VEGFR c Kit FLT3 FGFR | ||
结构式
本页面部分数据来自于公开的网络资源,所以瀚香生物不能保证其准确性。
不同批次的产品详情请咨询我们的客服：
- 全国免费电话：400-099-8200
- 在线客服:
瀚香生物（Biochempartner) 的所有产品和服务仅用于科学研究，禁止用于人体和治疗！